nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A7—Simvastatin—atherosclerosis	0.0418	0.0581	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0418	0.0581	CbGbCtD
Fluvoxamine—CYP3A7—Lovastatin—atherosclerosis	0.0409	0.0569	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0409	0.0569	CbGbCtD
Fluvoxamine—CYP2B6—Simvastatin—atherosclerosis	0.0398	0.0553	CbGbCtD
Fluvoxamine—CYP3A5—Rosuvastatin—atherosclerosis	0.0337	0.0469	CbGbCtD
Fluvoxamine—CYP3A5—Simvastatin—atherosclerosis	0.0313	0.0436	CbGbCtD
Fluvoxamine—CYP3A5—Pravastatin—atherosclerosis	0.0307	0.0427	CbGbCtD
Fluvoxamine—CYP3A5—Lovastatin—atherosclerosis	0.0307	0.0427	CbGbCtD
Fluvoxamine—CYP2C19—Rosuvastatin—atherosclerosis	0.0272	0.0378	CbGbCtD
Fluvoxamine—CYP2C19—Simvastatin—atherosclerosis	0.0253	0.0352	CbGbCtD
Fluvoxamine—CYP2C19—Lovastatin—atherosclerosis	0.0247	0.0344	CbGbCtD
Fluvoxamine—CYP2D6—Niacin—atherosclerosis	0.0243	0.0338	CbGbCtD
Fluvoxamine—CYP2C9—Rosuvastatin—atherosclerosis	0.0226	0.0314	CbGbCtD
Fluvoxamine—ABCB1—Ezetimibe—atherosclerosis	0.0219	0.0305	CbGbCtD
Fluvoxamine—CYP2C9—Simvastatin—atherosclerosis	0.021	0.0292	CbGbCtD
Fluvoxamine—CYP2C9—Pravastatin—atherosclerosis	0.0206	0.0286	CbGbCtD
Fluvoxamine—CYP2C9—Lovastatin—atherosclerosis	0.0206	0.0286	CbGbCtD
Fluvoxamine—ABCB1—Simvastatin—atherosclerosis	0.0204	0.0284	CbGbCtD
Fluvoxamine—ABCB1—Lovastatin—atherosclerosis	0.02	0.0278	CbGbCtD
Fluvoxamine—ABCB1—Pravastatin—atherosclerosis	0.02	0.0278	CbGbCtD
Fluvoxamine—CYP2D6—Simvastatin—atherosclerosis	0.0192	0.0267	CbGbCtD
Fluvoxamine—CYP2D6—Pravastatin—atherosclerosis	0.0188	0.0262	CbGbCtD
Fluvoxamine—CYP2D6—Lovastatin—atherosclerosis	0.0188	0.0262	CbGbCtD
Fluvoxamine—CYP3A4—Rosuvastatin—atherosclerosis	0.0131	0.0183	CbGbCtD
Fluvoxamine—CYP3A4—Ezetimibe—atherosclerosis	0.0131	0.0183	CbGbCtD
Fluvoxamine—CYP3A4—Simvastatin—atherosclerosis	0.0122	0.017	CbGbCtD
Fluvoxamine—CYP3A4—Lovastatin—atherosclerosis	0.012	0.0166	CbGbCtD
Fluvoxamine—CYP3A4—Pravastatin—atherosclerosis	0.012	0.0166	CbGbCtD
Fluvoxamine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000289	0.00139	CcSEcCtD
Fluvoxamine—Anaemia—Ezetimibe—atherosclerosis	0.000288	0.00138	CcSEcCtD
Fluvoxamine—Tinnitus—Pravastatin—atherosclerosis	0.000288	0.00138	CcSEcCtD
Fluvoxamine—Malaise—Lovastatin—atherosclerosis	0.000286	0.00137	CcSEcCtD
Fluvoxamine—Cardiac disorder—Pravastatin—atherosclerosis	0.000286	0.00137	CcSEcCtD
Fluvoxamine—Muscle spasms—Simvastatin—atherosclerosis	0.000286	0.00137	CcSEcCtD
Fluvoxamine—Vertigo—Lovastatin—atherosclerosis	0.000285	0.00137	CcSEcCtD
Fluvoxamine—Angioedema—Ezetimibe—atherosclerosis	0.000285	0.00137	CcSEcCtD
Fluvoxamine—Angiopathy—Niacin—atherosclerosis	0.000284	0.00136	CcSEcCtD
Fluvoxamine—Leukopenia—Lovastatin—atherosclerosis	0.000284	0.00136	CcSEcCtD
Fluvoxamine—Chills—Niacin—atherosclerosis	0.000281	0.00135	CcSEcCtD
Fluvoxamine—Malaise—Ezetimibe—atherosclerosis	0.000281	0.00135	CcSEcCtD
Fluvoxamine—Vision blurred—Simvastatin—atherosclerosis	0.00028	0.00134	CcSEcCtD
Fluvoxamine—Arrhythmia—Niacin—atherosclerosis	0.00028	0.00134	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000279	0.00134	CcSEcCtD
Fluvoxamine—Tremor—Simvastatin—atherosclerosis	0.000278	0.00134	CcSEcCtD
Fluvoxamine—Alopecia—Niacin—atherosclerosis	0.000277	0.00133	CcSEcCtD
Fluvoxamine—Chills—Pravastatin—atherosclerosis	0.000277	0.00133	CcSEcCtD
Fluvoxamine—Insomnia—Rosuvastatin—atherosclerosis	0.000277	0.00133	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000276	0.00132	CcSEcCtD
Fluvoxamine—Arrhythmia—Pravastatin—atherosclerosis	0.000276	0.00132	CcSEcCtD
Fluvoxamine—Palpitations—Ezetimibe—atherosclerosis	0.000275	0.00132	CcSEcCtD
Fluvoxamine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000275	0.00132	CcSEcCtD
Fluvoxamine—Anaemia—Simvastatin—atherosclerosis	0.000275	0.00132	CcSEcCtD
Fluvoxamine—Malnutrition—Niacin—atherosclerosis	0.000273	0.00131	CcSEcCtD
Fluvoxamine—Alopecia—Pravastatin—atherosclerosis	0.000273	0.00131	CcSEcCtD
Fluvoxamine—Cough—Ezetimibe—atherosclerosis	0.000272	0.0013	CcSEcCtD
Fluvoxamine—Angioedema—Simvastatin—atherosclerosis	0.000271	0.0013	CcSEcCtD
Fluvoxamine—Chest pain—Lovastatin—atherosclerosis	0.00027	0.0013	CcSEcCtD
Fluvoxamine—Myalgia—Lovastatin—atherosclerosis	0.00027	0.0013	CcSEcCtD
Fluvoxamine—Arthralgia—Lovastatin—atherosclerosis	0.00027	0.0013	CcSEcCtD
Fluvoxamine—Anxiety—Lovastatin—atherosclerosis	0.000269	0.00129	CcSEcCtD
Fluvoxamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000269	0.00129	CcSEcCtD
Fluvoxamine—Hypertension—Ezetimibe—atherosclerosis	0.000269	0.00129	CcSEcCtD
Fluvoxamine—Flatulence—Niacin—atherosclerosis	0.000269	0.00129	CcSEcCtD
Fluvoxamine—Malaise—Simvastatin—atherosclerosis	0.000268	0.00129	CcSEcCtD
Fluvoxamine—Tension—Niacin—atherosclerosis	0.000268	0.00128	CcSEcCtD
Fluvoxamine—Discomfort—Lovastatin—atherosclerosis	0.000267	0.00128	CcSEcCtD
Fluvoxamine—Vertigo—Simvastatin—atherosclerosis	0.000267	0.00128	CcSEcCtD
Fluvoxamine—Leukopenia—Simvastatin—atherosclerosis	0.000266	0.00128	CcSEcCtD
Fluvoxamine—Chest pain—Ezetimibe—atherosclerosis	0.000265	0.00127	CcSEcCtD
Fluvoxamine—Myalgia—Ezetimibe—atherosclerosis	0.000265	0.00127	CcSEcCtD
Fluvoxamine—Arthralgia—Ezetimibe—atherosclerosis	0.000265	0.00127	CcSEcCtD
Fluvoxamine—Nervousness—Niacin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Fluvoxamine—Flatulence—Pravastatin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Fluvoxamine—Dry mouth—Lovastatin—atherosclerosis	0.000264	0.00127	CcSEcCtD
Fluvoxamine—Tension—Pravastatin—atherosclerosis	0.000264	0.00126	CcSEcCtD
Fluvoxamine—Dysgeusia—Pravastatin—atherosclerosis	0.000263	0.00126	CcSEcCtD
Fluvoxamine—Muscle spasms—Niacin—atherosclerosis	0.000262	0.00126	CcSEcCtD
Fluvoxamine—Discomfort—Ezetimibe—atherosclerosis	0.000262	0.00126	CcSEcCtD
Fluvoxamine—Constipation—Rosuvastatin—atherosclerosis	0.000262	0.00125	CcSEcCtD
Fluvoxamine—Pain—Rosuvastatin—atherosclerosis	0.000262	0.00125	CcSEcCtD
Fluvoxamine—Confusional state—Lovastatin—atherosclerosis	0.000261	0.00125	CcSEcCtD
Fluvoxamine—Nervousness—Pravastatin—atherosclerosis	0.000261	0.00125	CcSEcCtD
Fluvoxamine—Dry mouth—Ezetimibe—atherosclerosis	0.000259	0.00124	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000259	0.00124	CcSEcCtD
Fluvoxamine—Muscle spasms—Pravastatin—atherosclerosis	0.000258	0.00124	CcSEcCtD
Fluvoxamine—Infection—Lovastatin—atherosclerosis	0.000257	0.00124	CcSEcCtD
Fluvoxamine—Vision blurred—Niacin—atherosclerosis	0.000257	0.00123	CcSEcCtD
Fluvoxamine—Confusional state—Ezetimibe—atherosclerosis	0.000256	0.00123	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000254	0.00122	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000254	0.00122	CcSEcCtD
Fluvoxamine—Vision blurred—Pravastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Fluvoxamine—Myalgia—Simvastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Fluvoxamine—Arthralgia—Simvastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Fluvoxamine—Chest pain—Simvastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Fluvoxamine—Infection—Ezetimibe—atherosclerosis	0.000253	0.00121	CcSEcCtD
Fluvoxamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000252	0.00121	CcSEcCtD
Fluvoxamine—Anxiety—Simvastatin—atherosclerosis	0.000252	0.00121	CcSEcCtD
Fluvoxamine—Tremor—Pravastatin—atherosclerosis	0.000252	0.00121	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00025	0.0012	CcSEcCtD
Fluvoxamine—Discomfort—Simvastatin—atherosclerosis	0.00025	0.0012	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000249	0.0012	CcSEcCtD
Fluvoxamine—Angioedema—Niacin—atherosclerosis	0.000249	0.0012	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000249	0.0012	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000249	0.00119	CcSEcCtD
Fluvoxamine—Anaemia—Pravastatin—atherosclerosis	0.000248	0.00119	CcSEcCtD
Fluvoxamine—Anorexia—Lovastatin—atherosclerosis	0.000247	0.00119	CcSEcCtD
Fluvoxamine—Angioedema—Pravastatin—atherosclerosis	0.000245	0.00118	CcSEcCtD
Fluvoxamine—Vertigo—Niacin—atherosclerosis	0.000245	0.00118	CcSEcCtD
Fluvoxamine—Syncope—Niacin—atherosclerosis	0.000245	0.00117	CcSEcCtD
Fluvoxamine—Confusional state—Simvastatin—atherosclerosis	0.000244	0.00117	CcSEcCtD
Fluvoxamine—Leukopenia—Niacin—atherosclerosis	0.000244	0.00117	CcSEcCtD
Fluvoxamine—Urticaria—Rosuvastatin—atherosclerosis	0.000243	0.00117	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000242	0.00116	CcSEcCtD
Fluvoxamine—Oedema—Simvastatin—atherosclerosis	0.000242	0.00116	CcSEcCtD
Fluvoxamine—Malaise—Pravastatin—atherosclerosis	0.000242	0.00116	CcSEcCtD
Fluvoxamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000242	0.00116	CcSEcCtD
Fluvoxamine—Vertigo—Pravastatin—atherosclerosis	0.000241	0.00116	CcSEcCtD
Fluvoxamine—Palpitations—Niacin—atherosclerosis	0.000241	0.00116	CcSEcCtD
Fluvoxamine—Infection—Simvastatin—atherosclerosis	0.000241	0.00116	CcSEcCtD
Fluvoxamine—Leukopenia—Pravastatin—atherosclerosis	0.00024	0.00115	CcSEcCtD
Fluvoxamine—Loss of consciousness—Niacin—atherosclerosis	0.00024	0.00115	CcSEcCtD
Fluvoxamine—Cough—Niacin—atherosclerosis	0.000238	0.00114	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000237	0.00114	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000236	0.00113	CcSEcCtD
Fluvoxamine—Insomnia—Lovastatin—atherosclerosis	0.000234	0.00112	CcSEcCtD
Fluvoxamine—Cough—Pravastatin—atherosclerosis	0.000234	0.00112	CcSEcCtD
Fluvoxamine—Paraesthesia—Lovastatin—atherosclerosis	0.000233	0.00112	CcSEcCtD
Fluvoxamine—Arthralgia—Niacin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Fluvoxamine—Myalgia—Niacin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Fluvoxamine—Hypertension—Pravastatin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000232	0.00111	CcSEcCtD
Fluvoxamine—Anorexia—Simvastatin—atherosclerosis	0.000231	0.00111	CcSEcCtD
Fluvoxamine—Dyspnoea—Lovastatin—atherosclerosis	0.000231	0.00111	CcSEcCtD
Fluvoxamine—Insomnia—Ezetimibe—atherosclerosis	0.00023	0.0011	CcSEcCtD
Fluvoxamine—Myalgia—Pravastatin—atherosclerosis	0.000229	0.0011	CcSEcCtD
Fluvoxamine—Chest pain—Pravastatin—atherosclerosis	0.000229	0.0011	CcSEcCtD
Fluvoxamine—Arthralgia—Pravastatin—atherosclerosis	0.000229	0.0011	CcSEcCtD
Fluvoxamine—Paraesthesia—Ezetimibe—atherosclerosis	0.000228	0.0011	CcSEcCtD
Fluvoxamine—Dyspepsia—Lovastatin—atherosclerosis	0.000228	0.00109	CcSEcCtD
Fluvoxamine—Anxiety—Pravastatin—atherosclerosis	0.000228	0.00109	CcSEcCtD
Fluvoxamine—Dry mouth—Niacin—atherosclerosis	0.000227	0.00109	CcSEcCtD
Fluvoxamine—Dyspnoea—Ezetimibe—atherosclerosis	0.000227	0.00109	CcSEcCtD
Fluvoxamine—Discomfort—Pravastatin—atherosclerosis	0.000226	0.00108	CcSEcCtD
Fluvoxamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000225	0.00108	CcSEcCtD
Fluvoxamine—Decreased appetite—Lovastatin—atherosclerosis	0.000225	0.00108	CcSEcCtD
Fluvoxamine—Dyspepsia—Ezetimibe—atherosclerosis	0.000224	0.00107	CcSEcCtD
Fluvoxamine—Fatigue—Lovastatin—atherosclerosis	0.000223	0.00107	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Niacin—atherosclerosis	0.000223	0.00107	CcSEcCtD
Fluvoxamine—Oedema—Niacin—atherosclerosis	0.000223	0.00107	CcSEcCtD
Fluvoxamine—Constipation—Lovastatin—atherosclerosis	0.000222	0.00106	CcSEcCtD
Fluvoxamine—Pain—Lovastatin—atherosclerosis	0.000222	0.00106	CcSEcCtD
Fluvoxamine—Confusional state—Pravastatin—atherosclerosis	0.000221	0.00106	CcSEcCtD
Fluvoxamine—Decreased appetite—Ezetimibe—atherosclerosis	0.000221	0.00106	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000221	0.00106	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Asthenia—Rosuvastatin—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Insomnia—Simvastatin—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Oedema—Pravastatin—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Fatigue—Ezetimibe—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Shock—Niacin—atherosclerosis	0.000219	0.00105	CcSEcCtD
Fluvoxamine—Infection—Pravastatin—atherosclerosis	0.000218	0.00104	CcSEcCtD
Fluvoxamine—Paraesthesia—Simvastatin—atherosclerosis	0.000218	0.00104	CcSEcCtD
Fluvoxamine—Pain—Ezetimibe—atherosclerosis	0.000217	0.00104	CcSEcCtD
Fluvoxamine—Constipation—Ezetimibe—atherosclerosis	0.000217	0.00104	CcSEcCtD
Fluvoxamine—Tachycardia—Niacin—atherosclerosis	0.000217	0.00104	CcSEcCtD
Fluvoxamine—Pruritus—Rosuvastatin—atherosclerosis	0.000216	0.00104	CcSEcCtD
Fluvoxamine—Dyspnoea—Simvastatin—atherosclerosis	0.000216	0.00104	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Niacin—atherosclerosis	0.000215	0.00103	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000215	0.00103	CcSEcCtD
Fluvoxamine—Feeling abnormal—Lovastatin—atherosclerosis	0.000214	0.00102	CcSEcCtD
Fluvoxamine—Dyspepsia—Simvastatin—atherosclerosis	0.000213	0.00102	CcSEcCtD
Fluvoxamine—Anorexia—Niacin—atherosclerosis	0.000212	0.00102	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000212	0.00102	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000212	0.00102	CcSEcCtD
Fluvoxamine—Decreased appetite—Simvastatin—atherosclerosis	0.000211	0.00101	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000209	0.00101	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000209	0.001	CcSEcCtD
Fluvoxamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000209	0.001	CcSEcCtD
Fluvoxamine—Fatigue—Simvastatin—atherosclerosis	0.000209	0.001	CcSEcCtD
Fluvoxamine—Anorexia—Pravastatin—atherosclerosis	0.000209	0.001	CcSEcCtD
Fluvoxamine—Hypotension—Niacin—atherosclerosis	0.000208	0.000998	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000208	0.000998	CcSEcCtD
Fluvoxamine—Pain—Simvastatin—atherosclerosis	0.000207	0.000995	CcSEcCtD
Fluvoxamine—Constipation—Simvastatin—atherosclerosis	0.000207	0.000995	CcSEcCtD
Fluvoxamine—Urticaria—Lovastatin—atherosclerosis	0.000206	0.000988	CcSEcCtD
Fluvoxamine—Abdominal pain—Lovastatin—atherosclerosis	0.000205	0.000983	CcSEcCtD
Fluvoxamine—Body temperature increased—Lovastatin—atherosclerosis	0.000205	0.000983	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000203	0.000973	CcSEcCtD
Fluvoxamine—Dizziness—Rosuvastatin—atherosclerosis	0.000202	0.00097	CcSEcCtD
Fluvoxamine—Urticaria—Ezetimibe—atherosclerosis	0.000202	0.000969	CcSEcCtD
Fluvoxamine—Insomnia—Niacin—atherosclerosis	0.000201	0.000966	CcSEcCtD
Fluvoxamine—Body temperature increased—Ezetimibe—atherosclerosis	0.000201	0.000964	CcSEcCtD
Fluvoxamine—Abdominal pain—Ezetimibe—atherosclerosis	0.000201	0.000964	CcSEcCtD
Fluvoxamine—Paraesthesia—Niacin—atherosclerosis	0.0002	0.000959	CcSEcCtD
Fluvoxamine—Feeling abnormal—Simvastatin—atherosclerosis	0.0002	0.000959	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0002	0.000958	CcSEcCtD
Fluvoxamine—Dyspnoea—Niacin—atherosclerosis	0.000198	0.000952	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000198	0.000951	CcSEcCtD
Fluvoxamine—Insomnia—Pravastatin—atherosclerosis	0.000198	0.000951	CcSEcCtD
Fluvoxamine—Somnolence—Niacin—atherosclerosis	0.000198	0.00095	CcSEcCtD
Fluvoxamine—Paraesthesia—Pravastatin—atherosclerosis	0.000197	0.000944	CcSEcCtD
Fluvoxamine—Dyspepsia—Niacin—atherosclerosis	0.000196	0.00094	CcSEcCtD
Fluvoxamine—Dyspnoea—Pravastatin—atherosclerosis	0.000195	0.000938	CcSEcCtD
Fluvoxamine—Decreased appetite—Niacin—atherosclerosis	0.000194	0.000929	CcSEcCtD
Fluvoxamine—Dyspepsia—Pravastatin—atherosclerosis	0.000193	0.000926	CcSEcCtD
Fluvoxamine—Rash—Rosuvastatin—atherosclerosis	0.000193	0.000925	CcSEcCtD
Fluvoxamine—Dermatitis—Rosuvastatin—atherosclerosis	0.000193	0.000924	CcSEcCtD
Fluvoxamine—Urticaria—Simvastatin—atherosclerosis	0.000193	0.000924	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000192	0.000922	CcSEcCtD
Fluvoxamine—Body temperature increased—Simvastatin—atherosclerosis	0.000192	0.00092	CcSEcCtD
Fluvoxamine—Abdominal pain—Simvastatin—atherosclerosis	0.000192	0.00092	CcSEcCtD
Fluvoxamine—Headache—Rosuvastatin—atherosclerosis	0.000192	0.000919	CcSEcCtD
Fluvoxamine—Hypersensitivity—Lovastatin—atherosclerosis	0.000191	0.000916	CcSEcCtD
Fluvoxamine—Decreased appetite—Pravastatin—atherosclerosis	0.000191	0.000914	CcSEcCtD
Fluvoxamine—Pain—Niacin—atherosclerosis	0.00019	0.000913	CcSEcCtD
Fluvoxamine—Fatigue—Pravastatin—atherosclerosis	0.000189	0.000907	CcSEcCtD
Fluvoxamine—Pain—Pravastatin—atherosclerosis	0.000187	0.000899	CcSEcCtD
Fluvoxamine—Constipation—Pravastatin—atherosclerosis	0.000187	0.000899	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000187	0.000899	CcSEcCtD
Fluvoxamine—Asthenia—Lovastatin—atherosclerosis	0.000186	0.000892	CcSEcCtD
Fluvoxamine—Pruritus—Lovastatin—atherosclerosis	0.000183	0.00088	CcSEcCtD
Fluvoxamine—Asthenia—Ezetimibe—atherosclerosis	0.000182	0.000875	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Niacin—atherosclerosis	0.000182	0.000873	CcSEcCtD
Fluvoxamine—Nausea—Rosuvastatin—atherosclerosis	0.000182	0.000872	CcSEcCtD
Fluvoxamine—Feeling abnormal—Pravastatin—atherosclerosis	0.000181	0.000867	CcSEcCtD
Fluvoxamine—Pruritus—Ezetimibe—atherosclerosis	0.00018	0.000863	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000179	0.00086	CcSEcCtD
Fluvoxamine—Hypersensitivity—Simvastatin—atherosclerosis	0.000179	0.000857	CcSEcCtD
Fluvoxamine—Diarrhoea—Lovastatin—atherosclerosis	0.000177	0.000851	CcSEcCtD
Fluvoxamine—Urticaria—Niacin—atherosclerosis	0.000177	0.000849	CcSEcCtD
Fluvoxamine—Abdominal pain—Niacin—atherosclerosis	0.000176	0.000844	CcSEcCtD
Fluvoxamine—Body temperature increased—Niacin—atherosclerosis	0.000176	0.000844	CcSEcCtD
Fluvoxamine—Urticaria—Pravastatin—atherosclerosis	0.000174	0.000836	CcSEcCtD
Fluvoxamine—Asthenia—Simvastatin—atherosclerosis	0.000174	0.000835	CcSEcCtD
Fluvoxamine—Diarrhoea—Ezetimibe—atherosclerosis	0.000174	0.000835	CcSEcCtD
Fluvoxamine—Abdominal pain—Pravastatin—atherosclerosis	0.000173	0.000831	CcSEcCtD
Fluvoxamine—Body temperature increased—Pravastatin—atherosclerosis	0.000173	0.000831	CcSEcCtD
Fluvoxamine—Pruritus—Simvastatin—atherosclerosis	0.000172	0.000823	CcSEcCtD
Fluvoxamine—Dizziness—Lovastatin—atherosclerosis	0.000171	0.000822	CcSEcCtD
Fluvoxamine—Dizziness—Ezetimibe—atherosclerosis	0.000168	0.000807	CcSEcCtD
Fluvoxamine—Diarrhoea—Simvastatin—atherosclerosis	0.000166	0.000796	CcSEcCtD
Fluvoxamine—Vomiting—Lovastatin—atherosclerosis	0.000165	0.000791	CcSEcCtD
Fluvoxamine—Hypersensitivity—Niacin—atherosclerosis	0.000164	0.000787	CcSEcCtD
Fluvoxamine—Rash—Lovastatin—atherosclerosis	0.000163	0.000784	CcSEcCtD
Fluvoxamine—Dermatitis—Lovastatin—atherosclerosis	0.000163	0.000783	CcSEcCtD
Fluvoxamine—Headache—Lovastatin—atherosclerosis	0.000162	0.000779	CcSEcCtD
Fluvoxamine—Vomiting—Ezetimibe—atherosclerosis	0.000162	0.000776	CcSEcCtD
Fluvoxamine—Hypersensitivity—Pravastatin—atherosclerosis	0.000161	0.000775	CcSEcCtD
Fluvoxamine—Dizziness—Simvastatin—atherosclerosis	0.00016	0.000769	CcSEcCtD
Fluvoxamine—Rash—Ezetimibe—atherosclerosis	0.00016	0.000769	CcSEcCtD
Fluvoxamine—Dermatitis—Ezetimibe—atherosclerosis	0.00016	0.000768	CcSEcCtD
Fluvoxamine—Asthenia—Niacin—atherosclerosis	0.00016	0.000766	CcSEcCtD
Fluvoxamine—Headache—Ezetimibe—atherosclerosis	0.000159	0.000764	CcSEcCtD
Fluvoxamine—Pruritus—Niacin—atherosclerosis	0.000157	0.000756	CcSEcCtD
Fluvoxamine—Asthenia—Pravastatin—atherosclerosis	0.000157	0.000755	CcSEcCtD
Fluvoxamine—Pruritus—Pravastatin—atherosclerosis	0.000155	0.000744	CcSEcCtD
Fluvoxamine—Vomiting—Simvastatin—atherosclerosis	0.000154	0.00074	CcSEcCtD
Fluvoxamine—Nausea—Lovastatin—atherosclerosis	0.000154	0.000739	CcSEcCtD
Fluvoxamine—Rash—Simvastatin—atherosclerosis	0.000153	0.000733	CcSEcCtD
Fluvoxamine—Dermatitis—Simvastatin—atherosclerosis	0.000153	0.000733	CcSEcCtD
Fluvoxamine—Diarrhoea—Niacin—atherosclerosis	0.000152	0.000731	CcSEcCtD
Fluvoxamine—Headache—Simvastatin—atherosclerosis	0.000152	0.000729	CcSEcCtD
Fluvoxamine—Nausea—Ezetimibe—atherosclerosis	0.000151	0.000725	CcSEcCtD
Fluvoxamine—Diarrhoea—Pravastatin—atherosclerosis	0.00015	0.00072	CcSEcCtD
Fluvoxamine—Dizziness—Niacin—atherosclerosis	0.000147	0.000706	CcSEcCtD
Fluvoxamine—Dizziness—Pravastatin—atherosclerosis	0.000145	0.000695	CcSEcCtD
Fluvoxamine—Nausea—Simvastatin—atherosclerosis	0.000144	0.000691	CcSEcCtD
Fluvoxamine—Vomiting—Niacin—atherosclerosis	0.000142	0.000679	CcSEcCtD
Fluvoxamine—Rash—Niacin—atherosclerosis	0.00014	0.000674	CcSEcCtD
Fluvoxamine—Dermatitis—Niacin—atherosclerosis	0.00014	0.000673	CcSEcCtD
Fluvoxamine—Headache—Niacin—atherosclerosis	0.000139	0.000669	CcSEcCtD
Fluvoxamine—Vomiting—Pravastatin—atherosclerosis	0.000139	0.000669	CcSEcCtD
Fluvoxamine—Rash—Pravastatin—atherosclerosis	0.000138	0.000663	CcSEcCtD
Fluvoxamine—Dermatitis—Pravastatin—atherosclerosis	0.000138	0.000663	CcSEcCtD
Fluvoxamine—Headache—Pravastatin—atherosclerosis	0.000137	0.000659	CcSEcCtD
Fluvoxamine—Nausea—Niacin—atherosclerosis	0.000132	0.000634	CcSEcCtD
Fluvoxamine—Nausea—Pravastatin—atherosclerosis	0.00013	0.000625	CcSEcCtD
Fluvoxamine—CYP2C9—Metabolism—LDLR—atherosclerosis	9.3e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.29e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.24e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CETP—atherosclerosis	9.16e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.15e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.13e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—atherosclerosis	9.12e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CETP—atherosclerosis	9.08e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALOX5—atherosclerosis	9.03e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMGCR—atherosclerosis	9.01e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—atherosclerosis	8.93e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—atherosclerosis	8.91e-06	0.000123	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMGCR—atherosclerosis	8.79e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.77e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOB—atherosclerosis	8.73e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.7e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.64e-06	0.000119	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.62e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOB—atherosclerosis	8.55e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOB—atherosclerosis	8.53e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CG—atherosclerosis	8.53e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—atherosclerosis	8.49e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.47e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—atherosclerosis	8.42e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.34e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—LPL—atherosclerosis	8.34e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—atherosclerosis	8.32e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—atherosclerosis	8.3e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMGCR—atherosclerosis	8.29e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—atherosclerosis	8.23e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMGCR—atherosclerosis	8.21e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.19e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA2—atherosclerosis	8.19e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.19e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.19e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—LPL—atherosclerosis	8.17e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—LPL—atherosclerosis	8.15e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GPX1—atherosclerosis	8.13e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.13e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NAMPT—atherosclerosis	8.1e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.09e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—INS—atherosclerosis	8.07e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOB—atherosclerosis	8.06e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.05e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LIPC—atherosclerosis	8.04e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCA1—atherosclerosis	8.03e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOC3—atherosclerosis	7.99e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GPX1—atherosclerosis	7.97e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GPX1—atherosclerosis	7.95e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LDLR—atherosclerosis	7.95e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CD36—atherosclerosis	7.92e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—atherosclerosis	7.84e-06	0.000108	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCA1—atherosclerosis	7.84e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPA—atherosclerosis	7.82e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CETP—atherosclerosis	7.76e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CD36—atherosclerosis	7.76e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CD36—atherosclerosis	7.74e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—LPL—atherosclerosis	7.7e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BGN—atherosclerosis	7.57e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—atherosclerosis	7.51e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—atherosclerosis	7.51e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA5—atherosclerosis	7.49e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SCARB1—atherosclerosis	7.43e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.41e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—atherosclerosis	7.4e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCA1—atherosclerosis	7.38e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARA—atherosclerosis	7.36e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—atherosclerosis	7.35e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.34e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.32e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CD36—atherosclerosis	7.32e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.24e-06	9.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARA—atherosclerosis	7.21e-06	9.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.21e-06	9.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARA—atherosclerosis	7.2e-06	9.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AGT—atherosclerosis	7.13e-06	9.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—atherosclerosis	7.08e-06	9.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.02e-06	9.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—atherosclerosis	6.99e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AGT—atherosclerosis	6.99e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AGT—atherosclerosis	6.97e-06	9.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.97e-06	9.62e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—atherosclerosis	6.93e-06	9.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—atherosclerosis	6.92e-06	9.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOA1—atherosclerosis	6.91e-06	9.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.89e-06	9.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—atherosclerosis	6.85e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—atherosclerosis	6.83e-06	9.43e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARA—atherosclerosis	6.8e-06	9.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—atherosclerosis	6.78e-06	9.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—atherosclerosis	6.77e-06	9.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOA1—atherosclerosis	6.77e-06	9.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOA1—atherosclerosis	6.75e-06	9.33e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—atherosclerosis	6.72e-06	9.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOB—atherosclerosis	6.6e-06	9.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AGT—atherosclerosis	6.59e-06	9.1e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—atherosclerosis	6.48e-06	8.94e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—atherosclerosis	6.45e-06	8.91e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOB—atherosclerosis	6.44e-06	8.89e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.42e-06	8.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—atherosclerosis	6.39e-06	8.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOA1—atherosclerosis	6.38e-06	8.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.34e-06	8.75e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.33e-06	8.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	6.31e-06	8.71e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—atherosclerosis	6.3e-06	8.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.28e-06	8.67e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—atherosclerosis	6.27e-06	8.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCA1—atherosclerosis	6.26e-06	8.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.25e-06	8.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.21e-06	8.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	6.18e-06	8.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.17e-06	8.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.17e-06	8.51e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—atherosclerosis	6.15e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—atherosclerosis	6.15e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.13e-06	8.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—atherosclerosis	6.09e-06	8.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOB—atherosclerosis	6.07e-06	8.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOB—atherosclerosis	6.02e-06	8.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—atherosclerosis	6e-06	8.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CETP—atherosclerosis	5.99e-06	8.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD36—atherosclerosis	5.99e-06	8.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—atherosclerosis	5.97e-06	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—atherosclerosis	5.96e-06	8.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—atherosclerosis	5.95e-06	8.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.9e-06	8.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.85e-06	8.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—atherosclerosis	5.85e-06	8.08e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD36—atherosclerosis	5.84e-06	8.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—atherosclerosis	5.84e-06	8.06e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	5.82e-06	8.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—atherosclerosis	5.79e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—atherosclerosis	5.74e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.74e-06	7.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.67e-06	7.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—atherosclerosis	5.65e-06	7.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—atherosclerosis	5.62e-06	7.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—atherosclerosis	5.6e-06	7.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARA—atherosclerosis	5.57e-06	7.69e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—atherosclerosis	5.54e-06	7.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—atherosclerosis	5.51e-06	7.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD36—atherosclerosis	5.51e-06	7.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—atherosclerosis	5.47e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD36—atherosclerosis	5.46e-06	7.54e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARA—atherosclerosis	5.43e-06	7.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.42e-06	7.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AGT—atherosclerosis	5.39e-06	7.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—atherosclerosis	5.37e-06	7.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—atherosclerosis	5.36e-06	7.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—atherosclerosis	5.35e-06	7.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—atherosclerosis	5.28e-06	7.29e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AGT—atherosclerosis	5.26e-06	7.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—atherosclerosis	5.24e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—atherosclerosis	5.23e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOA1—atherosclerosis	5.22e-06	7.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.22e-06	7.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.17e-06	7.14e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—atherosclerosis	5.15e-06	7.12e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOB—atherosclerosis	5.14e-06	7.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—atherosclerosis	5.13e-06	7.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARA—atherosclerosis	5.12e-06	7.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—atherosclerosis	5.12e-06	7.07e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—atherosclerosis	5.11e-06	7.05e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOA1—atherosclerosis	5.1e-06	7.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARA—atherosclerosis	5.07e-06	7.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—atherosclerosis	5.05e-06	6.98e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—atherosclerosis	5e-06	6.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AGT—atherosclerosis	4.96e-06	6.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AGT—atherosclerosis	4.91e-06	6.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—atherosclerosis	4.91e-06	6.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—atherosclerosis	4.86e-06	6.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—atherosclerosis	4.83e-06	6.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.83e-06	6.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—atherosclerosis	4.82e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—atherosclerosis	4.81e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOA1—atherosclerosis	4.8e-06	6.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—atherosclerosis	4.79e-06	6.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—atherosclerosis	4.79e-06	6.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—atherosclerosis	4.77e-06	6.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.77e-06	6.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOA1—atherosclerosis	4.76e-06	6.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—atherosclerosis	4.69e-06	6.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.68e-06	6.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD36—atherosclerosis	4.66e-06	6.44e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.65e-06	6.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—atherosclerosis	4.6e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—atherosclerosis	4.51e-06	6.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—atherosclerosis	4.49e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—atherosclerosis	4.42e-06	6.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.42e-06	6.1e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—atherosclerosis	4.4e-06	6.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.38e-06	6.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.35e-06	6e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARA—atherosclerosis	4.34e-06	5.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—atherosclerosis	4.23e-06	5.84e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AGT—atherosclerosis	4.2e-06	5.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—atherosclerosis	4.19e-06	5.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—atherosclerosis	4.15e-06	5.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.14e-06	5.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—atherosclerosis	4.14e-06	5.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—atherosclerosis	4.12e-06	5.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—atherosclerosis	4.11e-06	5.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—atherosclerosis	4.08e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOA1—atherosclerosis	4.07e-06	5.62e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—atherosclerosis	4.04e-06	5.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOB—atherosclerosis	3.97e-06	5.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—atherosclerosis	3.96e-06	5.46e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—atherosclerosis	3.86e-06	5.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.86e-06	5.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—atherosclerosis	3.8e-06	5.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—atherosclerosis	3.79e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—atherosclerosis	3.77e-06	5.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.71e-06	5.13e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—atherosclerosis	3.7e-06	5.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.64e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.62e-06	5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—atherosclerosis	3.61e-06	4.98e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD36—atherosclerosis	3.6e-06	4.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—atherosclerosis	3.58e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—atherosclerosis	3.53e-06	4.88e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—atherosclerosis	3.52e-06	4.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.41e-06	4.71e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.35e-06	4.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.33e-06	4.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.3e-06	4.56e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—atherosclerosis	3.25e-06	4.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AGT—atherosclerosis	3.24e-06	4.48e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—atherosclerosis	3.22e-06	4.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—atherosclerosis	3.18e-06	4.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.15e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.14e-06	4.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.08e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.87e-06	3.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.82e-06	3.89e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.77e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—atherosclerosis	2.71e-06	3.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—atherosclerosis	2.49e-06	3.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—atherosclerosis	2.41e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.38e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—atherosclerosis	2.36e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—atherosclerosis	2.35e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—atherosclerosis	2.22e-06	3.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.18e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.82e-06	2.51e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—atherosclerosis	1.78e-06	2.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.67e-06	2.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.66e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.42e-06	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.09e-06	1.51e-05	CbGpPWpGaD
